| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |